DE60235544D1 - Stabile pulververabreichungsform zur inhalation - Google Patents

Stabile pulververabreichungsform zur inhalation

Info

Publication number
DE60235544D1
DE60235544D1 DE60235544T DE60235544T DE60235544D1 DE 60235544 D1 DE60235544 D1 DE 60235544D1 DE 60235544 T DE60235544 T DE 60235544T DE 60235544 T DE60235544 T DE 60235544T DE 60235544 D1 DE60235544 D1 DE 60235544D1
Authority
DE
Germany
Prior art keywords
inhalation
stable powder
powder administration
administration
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235544T
Other languages
German (de)
English (en)
Inventor
Frank M Etzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60235544D1 publication Critical patent/DE60235544D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60235544T 2001-06-20 2002-06-11 Stabile pulververabreichungsform zur inhalation Expired - Lifetime DE60235544D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/885,349 US6482429B1 (en) 2001-06-20 2001-06-20 Stable powder inhalation dosage formulation
PCT/US2002/018406 WO2003000240A2 (en) 2001-06-20 2002-06-11 Stable powder inhalation dosage formulation

Publications (1)

Publication Number Publication Date
DE60235544D1 true DE60235544D1 (de) 2010-04-15

Family

ID=25386707

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235544T Expired - Lifetime DE60235544D1 (de) 2001-06-20 2002-06-11 Stabile pulververabreichungsform zur inhalation

Country Status (9)

Country Link
US (1) US6482429B1 (enExample)
EP (1) EP1401409B1 (enExample)
JP (1) JP4348179B2 (enExample)
AT (1) ATE459346T1 (enExample)
CA (1) CA2446221C (enExample)
DE (1) DE60235544D1 (enExample)
ES (1) ES2339751T3 (enExample)
MX (1) MXPA03011517A (enExample)
WO (1) WO2003000240A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408499D0 (en) 1994-04-28 1994-06-22 Edwin Shirley Trucking Limited A releasable joint for joining two construction elements of a transportable stage assembly
AP1712A (en) * 2000-10-12 2007-01-24 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
CA2546454A1 (en) * 2003-11-18 2005-06-02 Yansong Shan Healthy pleasurable inhalation device
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
WO2007037249A1 (ja) * 2005-09-27 2007-04-05 Asahi Kasei Chemicals Corporation セロオリゴ糖含有組成物
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions

Also Published As

Publication number Publication date
US6482429B1 (en) 2002-11-19
ATE459346T1 (de) 2010-03-15
EP1401409A2 (en) 2004-03-31
EP1401409B1 (en) 2010-03-03
WO2003000240A2 (en) 2003-01-03
ES2339751T3 (es) 2010-05-25
WO2003000240A3 (en) 2003-03-06
MXPA03011517A (es) 2004-03-18
JP4348179B2 (ja) 2009-10-21
CA2446221A1 (en) 2003-01-03
CA2446221C (en) 2011-04-12
JP2004534813A (ja) 2004-11-18

Similar Documents

Publication Publication Date Title
ATE459346T1 (de) Stabile pulververabreichungsform zur inhalation
WO2003026559A3 (en) Nasal nebulizer
DE60115255D1 (de) Inhalator
MXPA04003465A (es) Tratamiento de enfermedades hiperproliferativas, con el uso de analogos activos de la vitamina d.
ATE342053T1 (de) Formulierungen zur inhalation
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
AU2002316820A1 (en) Powder inhaler formulations
MXPA04004173A (es) Formas orales de liberacion controlada utiles para la reduccion o prevencion de la ansiedad hacia la nicotina.
PL370889A1 (en) Vaginal delivery of drugs
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
ATE420762T1 (de) Systeme, verfahren und geräte zur herstellung von dosierungsformen
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
WO2004066912A3 (en) Anti-inflammatory compositions and uses thereof
NZ533994A (en) Amino alcohol derivative or phosphonic acid derivative and medicinal compostion containing these
ATE505184T1 (de) Medizinische aerosolformulierung
TNSN05046A1 (en) Method of preparing dry powder inhalation compositions
WO2004100926A3 (en) Delivery of agents using hydrolyzable leaving groups
PT1435991E (pt) Utilização de aplidina para o tratamento de cancro pancreático
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
WO2004062640A3 (de) Kapsel zur aufnahme eines inhalativ applizierbaren wirkstoffs
AU2002350362A1 (en) Use of an anti-microtubule agent for the treatment of uveitis
AU2003281257A1 (en) A novel use of rapamycin and structural analogues thereof
WO2002066025A3 (de) Wirkstoffkombination aus dem racemat des tramadols und dem (+)-o-desmethyltramadol
MXPA05011249A (es) Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition